Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics.

Yumi Aoki Yoshikazu TakaesuMasahiro SuzukiIsa OkajimaMasahiro TakeshimaAkiyoshi ShimuraTomohiro UtsumiNozomu KotoriiHidehisa YamashitaKenichi KuriyamaNorio WatanabeKazuo Mishima

Published in: Neuropsychopharmacology reports (2021)

We developed a DA for chronic insomnia considering discontinuation of BZD/BRZA hypnotics, which was acceptable for stakeholders. The developed DA was designed to support patients and healthcare providers to make a decision about whether to discontinue BZD/BRZA hypnotics.

Keyphrases

healthcare
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
sleep quality
drug induced